Skip to main content
Medical information Clinical review pending

Genetic Testing

Human Herpes Virus 7 HHV7 Qualitative PCR Test

Detects the presence of Human Herpes Virus 7 (HHV7) using a sensitive PCR test. Helps diagnose HHV7 infections and guide treatment.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 ml (2 mL min.) whole blood in a Lavender Top (EDTA) tube OR 3 ml (2 mL min.) cerebrospinal fluid (CSF) in a sterile screw-capped container.
Results
Reports are typically available on Wednesday or Saturday, depending on the submission day (Monday or Thursday by 11 am). Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required for this test. Confirm with the laboratory before booking.
Test priceKSh 10,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Human Herpes Virus 7 HHV7 Qualitative PCR Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms suggestive of HHV7 infection (e.g., fever, fatigue, rash)
  • ✓Diagnosis in immunocompromised individuals
  • ✓Evaluation of potential viral reactivation
  • ✓Confirmation of suspected HHV7 infection
  • ✓Monitoring treatment response in specific cases
02

In plain language

What this test helps you understand

This test is used to detect the presence of Human Herpes Virus 7 (HHV7) DNA in clinical specimens, aiding in the diagnosis of HHV7 infection.
The Human Herpes Virus 7 (HHV7) Qualitative PCR Test is a diagnostic tool used to identify the presence of HHV7 in the body. This test uses Real Time PCR technology for accurate detection. Understanding your herpes virus status is important for managing infections effectively. This test measures the presence of Human Herpes Virus 7 in blood or cerebrospinal fluid (CSF). PCR methodology detects even small amounts of the virus, making it a sensitive option. Individuals experiencing symptoms like fever, fatigue, or skin rashes, or those with weakened immune systems, may benefit from this test. Early detection allows for timely treatment and effective symptom management. Results indicate whether HHV7 is present or absent. A positive result requires discussion with your healthcare provider for next steps. A negative result suggests no detectable virus, but clinical context is important.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required for this test. Confirm with the laboratory before booking.
Sample3 ml (2 mL min.) whole blood in a Lavender Top (EDTA) tube OR 3 ml (2 mL min.) cerebrospinal fluid (CSF) in a sterile screw-capped container.
MethodologyReal Time Polymerase Chain Reaction (PCR).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects the presence of HHV7 DNA but does not differentiate between active and latent infection. A negative result does not completely rule out infection, especially if the viral load is low or the sample was collected during a latent phase. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Human Herpes Virus 7 (HHV7) is a common virus that usually causes mild or no symptoms, but can sometimes lead to illness, particularly in people with weakened immune systems.
A positive result indicates that HHV7 DNA was detected in your sample. You should discuss this result with your healthcare provider to understand its implications for your health.
A negative result means that HHV7 DNA was not detected in the sample. However, it doesn't completely rule out infection, especially if symptoms persist. Consult your doctor.
The sample is typically collected as a blood draw (using a lavender top tube) or a cerebrospinal fluid sample. Your doctor will advise on the appropriate collection method.
Blood collection involves a needle prick, which may cause brief discomfort. CSF collection is a more involved procedure performed by a medical professional.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp